Document ID: chunk:federal_register_of_legislation:F2024L01521:clause:1_28
Version: federal_register_of_legislation:F2024L01521
Segment Type: clause
Provision Reference: sch 1 cl 28
Character Range: 16788–17587

28  Schedule 1 (table)
After:
Olanzapine  Tablet 5 mg (orally disintegrating)  Oral  Zypine ODT  (a) between 1 February 2024 and 30 September 2024—4 months stock by reference to usual demand of the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 5 mg, Oral;
                                                                   (b) between 1 October 2024 and 31 March 2025—4 months stock by reference to usual demand of both the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 5 mg, Oral and the brand Zypine ODT of the pharmaceutical item Olanzapine, Tablet 5 mg (orally disintegrating), Oral, added together

insert:
Olanzapine  Tablet 7.5 mg  Oral  APO-OLANZAPINE  4 months stock by reference to usual demand of both Olanzapine APOTEX and APO-OLANZAPINE added together